Korsana Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 |
|---|---|---|
Revenue | $1,025 | $875 |
Gross Profit | 1,025 | 875 |
EBITDA | -799 | -976 |
Net Income | -799 | -976 |
Net Change In Cash | 1,025 | 875 |
Free Cash Flow | -1,579 | -264 |
Cash | 3,240 | 4,568 |
Basic Shares | 460 | 460 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $2,074 | $2,000 | $297 |
Gross Profit | 2,074 | 2,000 | -5,282 |
EBITDA | -3,528 | -3,057 | -18,181 |
EBIT | -18,246 | ||
Net Income | -3,528 | -3,057 | -44,078 |
Net Change In Cash | 2,074 | 2,000 | 297 |
Free Cash Flow | -3,314 | -4,333 | -40,611 |
Cash | 3,240 | 3,232 | 13,382 |
Basic Shares | 460 | 359 | 310 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.88 |
2026-03-31 | -$5.28 |
2025-12-31 | -$0.19 |
2025-09-30 | -$2.11 |